Section 333.7336 - Patient qualification review board; reimbursement; certification of designated pharmacies for participation in marihuana distribution; contract with national institute on drug abuse
PUBLIC HEALTH CODE (EXCERPT)
Act 368 of 1978
*****333.7336 THIS SECTION DOES NOT APPLY AFTER NOVEMBER 1, 1987: See (7) of 333.7336*****
333.7336 Patient qualification review board; reimbursement; certification of designated pharmacies for participation in marihuana distribution; contract with national institute on drug abuse for receipt of marihuana; transfer of marihuana to certified pharmacy for distribution to patient; prescription; annual report; sections inapplicable after November 1, 1987.
Sec. 7336.
(1) If necessary in order to meet federal requirements, the director may appoint a patient qualification review board to serve at the director's pleasure.
(2) Members of the board may be reimbursed for their attendance at meetings at a rate established pursuant to section 1216.
(3) The Michigan board of pharmacy shall certify to the department designated pharmacies licensed under part 177 for participation regarding the distribution of marihuana pursuant to section 7335 and this section. The designated pharmacies shall be representative of the most extensive geographical location area of this state as the Michigan board of pharmacy determines is feasible.
(4) The department shall apply to contract with the national institute on drug abuse for receipt of marihuana pursuant to regulations promulgated by the national institute on drug abuse, the food and drug administration, and the drug enforcement agency, and pursuant to section 7335 and this section.
(5) The department shall cause the marihuana to be used by a patient in the marihuana controlled substances therapeutic research program to be transferred to a certified pharmacy for distribution to the certified patient upon the written prescription of the certified physician pursuant to section 7335 and this section. The marihuana distributed under section 7335 and this section shall be distributed at cost.
(6) The department, in conjunction with the patient qualification review board, if appointed, annually shall report its findings and recommendations to the governor and the legislature, regarding the effectiveness of the marihuana controlled substances therapeutic research program.
(7) This section and sections 7212(2), 7214(e), and 7335 shall not apply after November 1, 1987.
History: Add. 1982, Act 352, Imd. Eff. Dec. 21, 1982
Compiler's Notes: Former MCL 333.7336, pertaining to patient qualification review board and certification of designated pharmacies for participation in marihuana distribution, expired November 1, 1982, pursuant to Act 125 of 1979.
Popular Name: Act 368